Peptron's animal half-life lead: competitors' is longer, and evidence for once-monthly human weight loss remains unclear
Predicted impact: Medium
Report questions drug half-life edge and monthly dosing evidence; follows earlier critical reports.
Comments
No comments yet. Start the conversation.
Comments are people's own views. Nothing here is financial advice.